MedPath

se of chitin-based medicament for the treatment in milk teeth.

Phase 3
Completed
Conditions
Health Condition 1: K040- Pulpitis
Registration Number
CTRI/2021/08/035696
Lead Sponsor
idhish Krishna R
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
46
Inclusion Criteria

1.Large carious lesion in an otherwise restorable primary tooth 2.No spontaneous pain.

3.More than two-thirds of the root length is still present 4.No sign of internal or external root resorption 5.Hemorrhage from the amputated pulp site is controlled within 5 minutes.

Exclusion Criteria

1.Not fulfilling the above-mentioned clinical or radiographic criteria.

2.Inability to achieve hemostasis within 5 minutes of pressure application with a moist cotton pellet.

3.Bright red bleeding at the amputated pulp site.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study aims to clinically and radiographically evaluate the success of Chitosan as a medicament for pulpotomy.Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
Chitosan can be used as an alternative to formocresol for pulpotomy procedure.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath